Automated insulin pump takes on type 1 diabetes in Head-to-Head trial

NCT ID NCT05409131

Completed Disease control Sponsor: Insulet Corporation Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested the Omnipod 5, an automated insulin delivery system, against standard insulin pumps in 196 adults with type 1 diabetes. Participants used their usual therapy for 14 days, then either switched to Omnipod 5 or stayed on their pump for 90 days. The goal was to see if the automated system improved time in healthy blood sugar range.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Omnipod 5 System (automated insulin delivery device)
What this could lead to: If it works, this could offer better blood sugar control with less effort for people with type 1 diabetes.
What could go wrong: This is a completed trial, but results may not apply to all patients. The device requires proper use and monitoring, and there is always a risk of device malfunction or skin reactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES

Contacts and locations

Locations

Atlanta Diabetes

Atlanta, Georgia, 30318, United States
CHRU de Montpellier, Hopital Lapeyronie - Departement d'endocrinologie, Diabete, Nutrition

Montpellier, France
Diabetes & Glandular Disease Clinic, P.A. (DGD Clinic)

San Antonio, Texas, 78229, United States
Hopital Lariboisiere - Centre Universitaire du Diabete et de ses Complications

Paris, France
Hopital Sud-Francilien

Corbeil-Essonnes, France
Hospices Civils de Lyon - Centre du diabete Diab-eCare

Lyon, France
Joslin Diabetes Center

Boston, Massachusetts, 02215, United States
Northwestern University

Evanston, Illinois, 60208, United States
Sansum Diabetes Research Institute

Santa Barbara, California, 93105, United States
Stanford University School of Medicine

Palo Alto, California, 94304, United States
State University of New York, Upstate Medical University

Syracuse, New York, 13244, United States
University of Colorado Denver

Denver, Colorado, 80045, United States
University of Virginia

Charlottesville, Virginia, 22903, United States
University of Washington

Seattle, Washington, 98109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.